| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1027363503 |
| P356 | DOI | 10.1007/PL00007766 |
| P698 | PubMed publication ID | 10991671 |
| P2093 | author name string | Foley P | |
| Riederer P | |||
| P433 | issue | S2 | |
| P921 | main subject | oxidative stress | Q898814 |
| Parkinson's disease | Q11085 | ||
| P304 | page(s) | II82-94 | |
| P577 | publication date | 2000-04-01 | |
| P1433 | published in | Journal of Neurology | Q6295649 |
| P1476 | title | Influence of neurotoxins and oxidative stress on the onset and progression of Parkinson's disease | |
| P478 | volume | 247 Suppl 2 |
| Q37350053 | A systematic review of nutritional risk factors of Parkinson's disease |
| Q30581632 | Autologous transplantation of GDNF-expressing mesenchymal stem cells protects against MPTP-induced damage in cynomolgus monkeys |
| Q36281313 | Basic studies on epigenetic carcinogenesis of low-dose exposure to 1-trichloromethyl-1,2,3,4-tetrahydro-β-carboline (TaClo) in vitro. |
| Q44126676 | Behavioral effects of aminochrome and dopachrome injected in the rat substantia nigra. |
| Q39179414 | Berberine chloride pretreatment exhibits neuroprotective effect against 6-hydroxydopamine-induced neuronal insult in rat. |
| Q48615461 | Can mesenchymal stem cells reduce vulnerability of dopaminergic neurons in the substantia nigra to oxidative insult in individuals at risk to Parkinson's disease? |
| Q39205347 | Carnosine exerts neuroprotective effect against 6-hydroxydopamine toxicity in hemiparkinsonian rat. |
| Q33521022 | Compounds from an unbiased chemical screen reverse both ER-to-Golgi trafficking defects and mitochondrial dysfunction in Parkinson's disease models |
| Q28214322 | Current evidence for neuroprotective effects of nicotine and caffeine against Parkinson's disease |
| Q39823008 | Cytotoxicity of dopaminochrome in the mesencephalic cell line, MN9D, is dependent upon oxidative stress |
| Q43875583 | Distinct role for microglia in rotenone-induced degeneration of dopaminergic neurons. |
| Q46399461 | Dopaminergic function in a family with the PARK6 form of autosomal recessive Parkinson's syndrome |
| Q36151216 | Dopaminergic regeneration by neurturin-overexpressing c17.2 neural stem cells in a rat model of Parkinson's disease |
| Q39367606 | Dopaminochrome induces caspase-independent apoptosis in the mesencephalic cell line, MN9D. |
| Q37295370 | Ectopic localization of FOXO3a protein in Lewy bodies in Lewy body dementia and Parkinson's disease |
| Q44166867 | Electrochemically assisted Fenton reaction: reaction of hydroxyl radicals with xenobiotics followed by on-line analysis with high-performance liquid chromatography/tandem mass spectrometry |
| Q40639063 | Evidence for increased oxidative stress in peroxisomal D-bifunctional protein deficiency |
| Q48362227 | Investigations of differences in iron oxidation state inside single neurons from substantia nigra of Parkinson's disease and control patients using the micro-XANES technique. |
| Q44572684 | Kainic acid lesion-induced nigral neuronal death |
| Q48450930 | Lack of up-regulation of ferritin is associated with sustained iron regulatory protein-1 binding activity in the substantia nigra of patients with Parkinson's disease |
| Q38729204 | Neuroprotective effect of thymoquinone, the nigella sativa bioactive compound, in 6-hydroxydopamine-induced hemi-parkinsonian rat model |
| Q35789018 | Nonselenium glutathione peroxidase in human brain : elevated levels in Parkinson's disease and dementia with lewy bodies |
| Q46724154 | Nrf2 inducer and cncC overexpression attenuates neurodegeneration due to α-synuclein in Drosophila |
| Q43263588 | Oxidative and non-oxidative mechanisms of neuronal cell death and apoptosis by L-3,4-dihydroxyphenylalanine (L-DOPA) and dopamine. |
| Q39714333 | Parkinson disease-associated DJ-1 is required for the expression of the glial cell line-derived neurotrophic factor receptor RET in human neuroblastoma cells. |
| Q44514385 | Radioimmunoassay of N-acetyl-N-formyl-5-methoxykynuramine (AFMK): a melatonin oxidative metabolite |
| Q39337416 | Real-time monitoring of superoxide generation and cytotoxicity in neuroblastoma mitochondria induced by 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline. |
| Q39651300 | Rg1 protects iron‐induced neurotoxicity through antioxidant and iron regulatory proteins in 6‐OHDA‐treated MES23.5 cells |
| Q39064625 | Selective susceptibility of human dopaminergic neural stem cells to dopamine-induced apoptosis |
| Q36799584 | Target- and mechanism-based therapeutics for neurodegenerative diseases: strength in numbers |
| Q41543167 | Terminalia arjuna's antioxidant effect in isolated perfused kidney |
| Q90206384 | The Association of Iron and the Pathologies of Parkinson's Diseases in MPTP/MPP+-Induced Neuronal Degeneration in Non-human Primates and in Cell Culture |
| Q39796945 | The neuroprotective functions of selenoprotein M and its role in cytosolic calcium regulation |
| Q39202533 | The neuroprotective potential of sinapic acid in the 6-hydroxydopamine-induced hemi-parkinsonian rat. |
| Q46437143 | Torsin-mediated protection from cellular stress in the dopaminergic neurons of Caenorhabditis elegans. |
| Q26766587 | Why is nitric oxide important for our brain? |
Search more.